# Comprehensive study of resveratrol associated to sulfadiazine in lymphocytes infected with Toxoplasma gondii: involvement of purinergic signaling in immune response

**Authors:** Nathieli Bianchin Bottari, Priscila Marquezan Copetti, Bianca Fagan Bissacotti, Taís Vidal, Anielen Dutra Da Silva, Mateus Fracasso, Karine Paula Reichert, Jelson Nauderer, Vera Maria Melchiors Morsch, Cinthia Melazzo, Aleksandro Schafer Da Silva, Maria Rosa Chitolina Schetinger

PMC · DOI: 10.1007/s11686-026-01252-x · Acta Parasitologica · 2026-03-17

## TL;DR

This study explores how resveratrol affects immune responses in lymphocytes infected with Toxoplasma gondii, suggesting it could be a potential treatment for toxoplasmosis.

## Contribution

The study identifies resveratrol's role in modulating purinergic signaling and immune responses during Toxoplasma gondii infection in lymphocytes.

## Key findings

- Resveratrol increased ATP and ADP hydrolysis in infected lymphocytes.
- Resveratrol upregulated P1 and P2 purinergic receptors in T. gondii-infected lymphocytes.
- Resveratrol showed anti-inflammatory and antioxidant effects through adenosine receptors.

## Abstract

Toxoplasma gondii is a highly successful intracellular pathogen. Its success is largely achieved by the parasite’s ability to avoid the host immune response. During  T. gondii infection lymphocytes play an active role in host defense and purinergic signaling has been shown to contribute to parasite control. Several studies have demonstrated the importance of ATP (adenosine triphosphate) signaling via purinergic receptor, as a component of the inflammatory response against  T. gondii. Here, we hypothesized whether RSV, a natural polyphenol, could be involved in  T. gondii control triggered by purinergic signaling, during acute infection in lymphocytes. Thus, the outcomes of this study were lymphocyte viability, modulation of ectonucleotidase activity, purinergic receptor expression and inflammatory mediators. T. gondii infection diminished lymphocytes viability 24h after RH-tachyzoites exposition. RSV treatment promote an increment of ATP, ADP hydrolysis by NTPDase (CD39) and adenosine deamination by ADA enzyme in infected lymphocytes. In addition, RSV upregulated P1 and P2 receptors in T. gondii-infected lymphocytes. There is an involvement of P2X7 receptor and proinflammatory cytokines in activated lymphocytes leading to ROS generation and nitrite production. However, the excessive damage is controlled by anti-inflammatory and antioxidant effects of RSV thought adenosine receptors and anti-inflammatory cytokine production. Together, our results suggest RSV isolate or combinate to sulfamethoxazole trimethoprim (choice drug for toxoplasmosis) could upregulate purinergic signaling during  T. gondii infection suggesting a therapeutical candidate target in toxoplasmosis.

The online version contains supplementary material available at 10.1007/s11686-026-01252-x.

## Linked entities

- **Proteins:** ADA (adenosine deaminase), P2RX7 (purinergic receptor P2X 7)
- **Chemicals:** resveratrol (PubChem CID 5056), ATP (PubChem CID 5957), ADP (PubChem CID 6022), adenosine (PubChem CID 60961), sulfamethoxazole trimethoprim (PubChem CID 358641)
- **Diseases:** toxoplasmosis (MONDO:0005989)
- **Species:** Toxoplasma gondii (taxon 5811)

## Full-text entities

- **Genes:** DPP4 (dipeptidyl peptidase 4) [NCBI Gene 1803] {aka ADABP, ADCP2, CD26, DPPIV, TP103}, NT5E (5'-nucleotidase ecto) [NCBI Gene 4907] {aka CALJA, CD73, E5NT, NT, NT5, NTE}, TADA1 (transcriptional adaptor 1) [NCBI Gene 117143] {aka ADA1, HFI1, STAF42, TADA1L, hADA1}, Sirt1 (sirtuin 1) [NCBI Gene 93759] {aka SIR2L1, Sir2, Sir2a, Sir2alpha}, ENTPD1 (ectonucleoside triphosphate diphosphohydrolase 1) [NCBI Gene 953] {aka ATP-DPH, ATPDase, CD39, NTPDase-1, SPG64}
- **Diseases:** tissue injury (MESH:D017695), inflammation (MESH:D007249), hypersensitivity (MESH:D004342), Alzheimer Disease (MESH:D000544), R-PE (MESH:C580424), infection (MESH:D007239), T. gondii (MESH:D014123), toxoplasmose (MESH:D014125)
- **Chemicals:** H2O2 (MESH:D006861), DMSO (MESH:D004121), inosine (MESH:D007288), phenol (MESH:D019800), Pi (MESH:D010716), Na+ (MESH:D012964), 3- [4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MESH:C022616), ADO (MESH:C110027), 2',7'-dichlorofluorescein diacetate (MESH:C029569), sulfonamides (MESH:D013449), inorganic phosphate (MESH:D010710), Bactrim (MESH:D015662), nucleoside (MESH:D009705), nitrosamine (MESH:D009602), isopropanol (MESH:D019840), MTT (MESH:C070243), water (MESH:D014867), trypan blue (MESH:D014343), Nucleotide (MESH:D009711), nitrogen (MESH:D009584), saline (MESH:D012965), sodium nitroprusside (MESH:D009599), ammonia (MESH:D000641), RH (MESH:D012238), Tween 20 (MESH:D011136), CO2 (MESH:D002245), polyphenol (MESH:D059808), ATP (MESH:D000255), AMP (MESH:D000249), malachite green (MESH:C005095), cAMP (MESH:D000242), PVDF (MESH:C024865), E-ADA (-), hypochlorite (MESH:D006997), nitrate (MESH:D009566), K+ (MESH:D011188), EDTA (MESH:D004492), Nitrite (MESH:D009573), ADP (MESH:D000244), glycerin (MESH:D005990), Sulfadiazina (MESH:D013411), RSV (MESH:D000077185), SDS (MESH:D012967), FITC (MESH:D016650), Adenosine (MESH:D000241)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Oscillospira sp. F (species) [taxon 227390], Toxoplasma gondii RH (strain) [taxon 383379], Toxoplasma gondii (species) [taxon 5811], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** A2A

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12995952/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12995952/full.md

---
Source: https://tomesphere.com/paper/PMC12995952